Breast cancer cell-derived factors have a greater effect on undifferentiated MPRO because one of the factors produced by breast cancer cells is G-CSF, a potent molecule to pull out immature or undifferentiated neutrophils from the bone marrow. This evidence concerns the gene CSF3 and breast cancer.